Stock SXTC CHINA SXT PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company China SXT Pharmaceuticals, Inc.

Equities

SXTC

VGG2161P1403

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 21:30:00 03/05/2024 BST 		5-day change 1st Jan Change
0.9605 USD -5.37% Intraday chart for China SXT Pharmaceuticals, Inc. -8.52% -75.81%
04-05 China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023 CI
02-08 Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected MT

Business Summary

China SXT Pharmaceuticals Inc is a China-based pharmaceutical company that focuses on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (TCMP). The Company develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP, and TCM Homologous Supplements (TCMHS) products. The Company sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. Most of its products are sold on a prescription basis across China.

Number of employees: 78

Sales per Business

USD in Million2022Weight2023Weight Delta
Regular Traditional Chinese Medicine Pieces
35.4 %
1 30.5 % 1 35.4 % -12.09%
Advanced Traditional Chinese Medicine Pieces
33.3 %
1 44.7 % 1 33.3 % -43.52%
Raw Medicinal Materials
25.5 %
- - 1 25.5 % -
Fine Traditional Chinese Medicine Pieces
5.8 %
0 15.4 % 0 5.8 % -71.28%

Sales per region

USD in Million2022Weight2023Weight Delta
China
100.0 %
3 100.0 % 2 100.0 % -24.23%

Managers

Managers TitleAgeSince
Feng Zhou CEO
 Chief Executive Officer 32 03/07/17
Xiaodong Pan DFI
 Director of Finance/CFO - 30/01/22
Peter Chan IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Feng Zhou CEO
 Chief Executive Officer 32 03/07/17
Jun Zheng BRD
 Director/Board Member 47 30/12/18
Xiaodong Ji BRD
 Director/Board Member 54 21/05/21
Tong Liu BRD
 Director/Board Member - 09/05/22
Songfan He BRD
 Director/Board Member - 09/05/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 565,533 441,071 ( 77.99 %) 0 77.99 %

Shareholders

NameEquities%Valuation
AVANZA BANK HOLDING AB
2.376 %
13,437 2.376 % 22 574 $
UBS Securities LLC
1.133 %
6,408 1.133 % 10 765 $
Feng Zhou
0.7515 %
4,250 0.7515 % 7 140 $
Acadian Asset Management LLC
0.4879 %
2,759 0.4879 % 4 635 $
Qube Research & Technologies Ltd. (France)
0.000530 %
3 0.000530 % 5 $
BANQUE CANTONALE VAUDOISE
0.000177 %
1 0.000177 % 2 $
The Lind Partners LLC
0.000000 %
0 0.000000 % - $

Company contact information

China Sxt Pharmaceuticals, Inc.

178 Taidong North Road

86298290, Taizhou

+86 523 8629 8290

http://www.sxtchina.com
address China SXT Pharmaceuticals, Inc.(SXTC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
CHINA SXT PHARMACEUTICALS, INC. Stock China SXT Pharmaceuticals, Inc.
-75.81% 699K
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SXTC Stock
  4. Company China SXT Pharmaceuticals, Inc.